Hospitalized oncology patients with diarrhea: Clinical outcomes and prognostic factors.

11136 Background: Diarrhea is a frequent cause of hospitalization in oncology patients and may lead to substantial morbidity and mortality. However, data on short-term outcomes and prognostic factors in hospitalized cancer patients with diarrhea are limited. This study aimed to evaluate clinical outcomes and identify factors associated with poor prognosis in this population. Methods: Medical records of 6,349 oncology patients hospitalized over a 3-year period were retrospectively reviewed. A total of 163 adult patients hospitalized primarily for diarrhea were included; patients with immune checkpoint inhibitor–related diarrhea were excluded. Collected variables included demographic characteristics, disease stage, Eastern Cooperative Oncology Group (ECOG) performance status, febrile neutropenia at admission, systemic anticancer therapy, serum albumin level, and diarrhea grade. Primary outcomes were intensive care unit (ICU) admission and 30-day mortality. Logistic regression analysis was used to identify independent predictors of mortality. Results: Diarrhea accounted for 2.6% of all oncology-related hospitalizations, and 83.4% of patients had grade ≥3 diarrhea. ICU admission was more frequent in patients with ECOG ≥2 compared with those with ECOG < 2 (42.4% vs 14.4%, p < 0.001) and in patients with grade ≥3 diarrhea (27.9% vs 7.4%, p = 0.024). The overall 30-day mortality rate was 16.0% and was higher in patients with ECOG ≥2 (39.0% vs 2.9%, p < 0.001), metastatic disease (23.5% vs 7.7%, p = 0.006), and grade ≥3 diarrhea (19.1% vs 0%, p = 0.009). Febrile neutropenia was not associated with ICU admission or mortality. In multivariable analysis, ECOG ≥2 (OR: 17.1, p < 0.001) and lower serum albumin level (OR: 0.42, p = 0.049) were independent predictors of 30-day mortality. Diarrhea grade was excluded from the multivariable model due to complete separation. Conclusions: Diarrhea in hospitalized oncology patients is associated with substantial ICU utilization and short-term mortality, independent of febrile neutropenia. Poor functional status and low serum albumin are key prognostic factors, highlighting that diarrhea should be regarded as a potentially life-threatening condition requiring early risk stratification and prompt supportive care.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2026-05-27
DOI
https://doi.org/10.1200/jco.2026.44.16_suppl.11136
Primary Topic
Neutropenia and Cancer Infections
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hospitalized oncology patients with diarrhea: Clinical outcomes and prognostic factors.

Özgen Ahmet Yıldırım, Güner Akgüner, Aysegul Ilhan
Journal of Clinical Oncology
Neutropenia and Cancer Infections
article

Hospitalized oncology patients with diarrhea: Clinical outcomes and prognostic factors.

Özgen Ahmet Yıldırım, Güner Akgüner, Aysegul Ilhan
article en

Abstract

11136 Background: Diarrhea is a frequent cause of hospitalization in oncology patients and may lead to substantial morbidity and mortality. However, data on short-term outcomes and prognostic factors in hospitalized cancer patients with diarrhea are limited. This study aimed to evaluate clinical outcomes and identify factors associated with poor prognosis in this population. Methods: Medical records of 6,349 oncology patients hospitalized over a 3-year period were retrospectively reviewed. A total of 163 adult patients hospitalized primarily for diarrhea were included; patients with immune checkpoint inhibitor–related diarrhea were excluded. Collected variables included demographic characteristics, disease stage, Eastern Cooperative Oncology Group (ECOG) performance status, febrile neutropenia at admission, systemic anticancer therapy, serum albumin level, and diarrhea grade. Primary outcomes were intensive care unit (ICU) admission and 30-day mortality. Logistic regression analysis was used to identify independent predictors of mortality. Results: Diarrhea accounted for 2.6% of all oncology-related hospitalizations, and 83.4% of patients had grade ≥3 diarrhea. ICU admission was more frequent in patients with ECOG ≥2 compared with those with ECOG < 2 (42.4% vs 14.4%, p < 0.001) and in patients with grade ≥3 diarrhea (27.9% vs 7.4%, p = 0.024). The overall 30-day mortality rate was 16.0% and was higher in patients with ECOG ≥2 (39.0% vs 2.9%, p < 0.001), metastatic disease (23.5% vs 7.7%, p = 0.006), and grade ≥3 diarrhea (19.1% vs 0%, p = 0.009). Febrile neutropenia was not associated with ICU admission or mortality. In multivariable analysis, ECOG ≥2 (OR: 17.1, p < 0.001) and lower serum albumin level (OR: 0.42, p = 0.049) were independent predictors of 30-day mortality. Diarrhea grade was excluded from the multivariable model due to complete separation. Conclusions: Diarrhea in hospitalized oncology patients is associated with substantial ICU utilization and short-term mortality, independent of febrile neutropenia. Poor functional status and low serum albumin are key prognostic factors, highlighting that diarrhea should be regarded as a potentially life-threatening condition requiring early risk stratification and prompt supportive care.

Journal of Clinical OncologyVol. 44(16_suppl)
Turkish Armed Forces (TR), Memorial Ankara Hospital (TR)
Good health and well-being
Openalex Percentile: Top 11%
Neutropenia and Cancer Infections
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.